Personal CFO Solutions’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-436	Closed	-$87K	–	514
2021 Q3	$87K	Sell	436 -20	-4%	-$3.99K	0.02%	439
2021 Q2	$79K	Hold	456	–	–	0.02%	428
2021 Q1	$90K	Hold	456	–	–	0.02%	393
2020 Q4	$90K	Buy	+456	New	+$90K	0.02%	361